To investigate the outcome of cardiac evaluation and the risk stratification for sudden cardiac death (SCD) in asymptomatic hypertrophic cardiomyopathy (HCM) mutation carriers. Seventy-six HCM mutation carriers from 32 families identified by predictive DNA testing underwent cardiac evaluation including history, examination, electrocardiography, Doppler echocardiography, exercise testing, and 24 h Holter monitoring. The published diagnostic criteria for HCM in adult members of affected families were used to diagnose HCM. Thirty-three (43%) men and 43 (57%) women with a mean age of 42 years (range 16-79) were examined; in 31 (41%) HCM was diagnosed. Disease penetrance was age related and men were more often affected than women (P = 0.04). Myo...
Over 1,500 gene mutations are known to cause hypertrophic cardiomyopathy (HCM). Previous studies sug...
The role of genetic testing over the clinical and functional variables, including data from the card...
Over 1,500 gene mutations are known to cause hypertrophic cardiomyopathy (HCM). Previous studies sug...
Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM) and o...
Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM) and o...
Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...
Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...
Hypertrophic cardiomyopathy is a primary myocardial disorder with an autosomal pattern of inheritanc...
Knowledge on the influence of specific genotypes on the phenotypic expression of hypertrophic cardio...
Over 1,500 gene mutations are known to cause hypertrophic cardiomyopathy (HCM). Previous studies sug...
The role of genetic testing over the clinical and functional variables, including data from the card...
Over 1,500 gene mutations are known to cause hypertrophic cardiomyopathy (HCM). Previous studies sug...
Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM) and o...
Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM) and o...
Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...
Aims We investigated the presence of a clinical diagnosis of hypertrophic cardiomyopathy (HCM), risk...
Hypertrophic cardiomyopathy is a primary myocardial disorder with an autosomal pattern of inheritanc...
Knowledge on the influence of specific genotypes on the phenotypic expression of hypertrophic cardio...
Over 1,500 gene mutations are known to cause hypertrophic cardiomyopathy (HCM). Previous studies sug...
The role of genetic testing over the clinical and functional variables, including data from the card...
Over 1,500 gene mutations are known to cause hypertrophic cardiomyopathy (HCM). Previous studies sug...